Literature DB >> 8475685

Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring.

J J van Hilten1, J F Kabel, H A Middelkoop, C G Kramer, G A Kerkhof, R A Roos.   

Abstract

The aim of this study was to examine the influence of response fluctuations with dyskinesia on the 24-h motor activity pattern and measures of diurnal and nocturnal activity and immobility. Motor activity was recorded during 5 successive days in 5 patients with advanced Parkinson's disease (PD) suffering from severe response fluctuations with dyskinesia, as well as in 10 PD patients with a stable levodopa response and 10 healthy subjects. The 24-h motor activity pattern of the patients with response fluctuations provides insight into the relationship between the therapeutic regimen and 1) the frequency and duration of "on" and "off" periods, 2) the severity of the dyskinesias, and 3) the degree of sleep disruption. In accordance with the severity of their motor fluctuations, patients with response fluctuations showed a large intra- and interindividual variability of diurnal motor activity measures. Overall, the nocturnal motor activity measures in the patients with response fluctuations indicated a severely disturbed sleep when compared with the two control groups. Factors as simplicity and the potential to record unrestrained motor activity for several days continuously in all settings, make activity monitoring a welcomed acquisition in the assessment of response fluctuations in PD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475685     DOI: 10.1111/j.1600-0404.1993.tb04096.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  11 in total

1.  Actimetry in sleep medicine.

Authors:  O Kellner; H Bastuji; P Adeleine
Journal:  Sleep Breath       Date:  1997-03       Impact factor: 2.816

Review 2.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

Review 3.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

4.  An ambulatory dyskinesia monitor.

Authors:  A J Manson; P Brown; J D O'Sullivan; P Asselman; D Buckwell; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

5.  Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.

Authors:  Aleksandar Videnovic; Charleston Noble; Kathryn J Reid; Jie Peng; Fred W Turek; Angelica Marconi; Alfred W Rademaker; Tanya Simuni; Cindy Zadikoff; Phyllis C Zee
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

6.  The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.

Authors:  Carrie B Hurelbrink; Simon J G Lewis; Roger A Barker
Journal:  J Neurol       Date:  2005-03-07       Impact factor: 4.849

Review 7.  Consequences of Circadian Disruption on Neurologic Health.

Authors:  Aleksandar Videnovic; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2015-09-26

Review 8.  Circadian system - A novel diagnostic and therapeutic target in Parkinson's disease?

Authors:  Aleksandar Videnovic; Gregory L Willis
Journal:  Mov Disord       Date:  2016-01-30       Impact factor: 10.338

9.  Circadian Dysregulation in Parkinson's Disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2016-11-12

10.  A Computational Analysis in a Cohort of Parkinson's Disease Patients and Clock-Modified Colorectal Cancer Cells Reveals Common Expression Alterations in Clock-Regulated Genes.

Authors:  Müge Yalçin; Deeksha Malhan; Alireza Basti; Ana Rita Peralta; Joaquim J Ferreira; Angela Relógio
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.